Despite possessing a solid data package on the potential of high-dose Sprinraza in spinal muscular atrophy (SMA), Biogen will ...

Generics of Gilead Sciences' twice-yearly HIV pre-exposure prophylaxis (PrEP) Yeztugo (lenacapavir) are on the horizon, with ...

Soleno Therapeutics is breathing easier with a report from Acadia Pharmaceuticals that its candidate to treat hyperphagia in ...

In his attempts to reduce drug prices in the U.S., President Donald Trump’s message to the rest of the world has been clear: ...

Excitement around Fujifilm Biotechnologies’ massive new cell culture facility in Holly Springs, North Carolina, has been ...

There’s no doubt that growing up on pandemic-era online schooling and TikTok trends has set the Generation Z experience apart ...

A Johnson & Johnson innovate medicine subsidiary, Janssen Vaccines, landed in hot water with the FDA this summer over a 2024 ...

After Madison Norman graduated with an undergraduate degree in business administration from Boston University and then a ...

Following a negative FDA advisory committee vote earlier this year, the other shoe has dropped for Lundbeck and Otsuka ...

In recent years, Roche has made a habit of oscillating between first and second place on rare disease patient groups’ annual ...

With a fresh endorsement from the FDA, Johnson & Johnson has rounded out Tremfya’s presence in inflammatory bowel disease ...

Separately, the ACIP members reversed their vote on a recommendation they’d shot down Thursday pertaining to coverage of ...